Cue Biopharma Inc (CUE) Annual Balance Sheets

Annual · GAAP · USD millions
Access CUE quarterly Balance Sheets →
The balance sheet data below highlights changes in Cue Biopharma Inc's financial position over recent quarters.
Annual Report, GAAP in USD millions
ITEM
(Dec 31 2025)
(Dec 31 2024) (Dec 31 2023) (Dec 31 2022) (Dec 31 2021)
Assets
Cash & cash equivalent27.14
Available-for-sale Securities, Debt Securities, Current MA0.00
Deposits Assets, Current AS1.09
Cash & Short-term Investments28.00
Accounts receivable5.55
Value Added Tax Receivable, Current1.90
Other Current Assets0.00
Prepaid Expense And Other Assets Current1.31
Total Current Assets36.98
Equipment/Property/Plant Net0.24
Deposits Assets, Noncurrent AS0.67
Other Assets, Noncurrent4.32
Restricted Cash Noncurrent0.15
Total Assets42.21
Liabilities
Accounts Payable, Current AC3.95
Accrued Liabilities, Current AC1.61
Other Loans Payable, Current OT0.69
Other Liabilities, Current7.25
Total Current Liabilities13.49
Long-term debt0.00
Other Long-term Debt, Current OT0.00
Total Long-term Debt0.00
Other liabilities, Noncurrent2.29
Research And Development Contract Liability Current5.34
Total Liabilities15.78
Stockholders' Equity
Common Stock Value0.10
Additional Paid In Capital Common Stock394.80
Retained Earnings / Accumulated Deficit-368.47
Other Equity0.00
Common Stockholder's Equity26.43
Total Stockholder's Equity26.43
Liabilities & Stockholder's Equity42.21
4 historic quarters locked

Sign in to unlock the full Cue Biopharma Inc balance sheet history.

About Cue Biopharma Inc Annual Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-K filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

  • Form: 10-K (Period: 20251231)
  • Filed with the SEC: March 16, 2026
  • Source: cue-20251231.htm

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001193125-26-108287

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.

Get the full CSIMarket dataset: Subscribe API License